Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Marchant

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
British Heart Journal|August 1, 1992
Streptokinase induced defibrination assessed by thrombin time: effects on residual coronary stenosis and left ventricular ejection fractionK Ranjadayalan, R Stevenson, B Marchant, et al.
Environmental Pollution (Barking, Essex : 1987)|May 12, 2025
A comparative analysis of PFAS in archive and fresh soil samples in England and implications for large-scale surveysD J Beriro, J M Bearcock, C H Vane, et al.
The New England Journal of Medicine|September 16, 1999
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study GroupC Torp-Pedersen, M Møller, P E Bloch-Thomsen, et al.
Clinical Trials (London, England)|June 2, 2023
Now is the time to fix the clinical research workforce crisisStephanie A Freel, Denise C Snyder, Kara Bastarache, et al.
Lancet (London, England)|January 6, 2001
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trialL Køber, P E Bloch Thomsen, M Møller, et al.
The Science of the Total Environment|April 10, 2024
Temporal drivers of tryptophan-like fluorescent dissolved organic matter along a river continuumN A Harris, J P R Sorensen, B Marchant, et al.
The Science of the Total Environment|March 21, 2025
Corrigendum to "Temporal drivers of tryptophan-like fluorescent dissolved organic matter along a river continuum" [Sci. Total Environ. (2024) 172285]N A Harris, J P R Sorensen, B Marchant, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Model-based drug development: a rational approach to efficiently accelerate drug developmentP A Milligan, M J Brown, B Marchant, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
British Heart Journal|August 1, 1992
Streptokinase induced defibrination assessed by thrombin time: effects on residual coronary stenosis and left ventricular ejection fractionK Ranjadayalan, R Stevenson, B Marchant, et al.
Environmental Pollution (Barking, Essex : 1987)|May 12, 2025
A comparative analysis of PFAS in archive and fresh soil samples in England and implications for large-scale surveysD J Beriro, J M Bearcock, C H Vane, et al.
The New England Journal of Medicine|September 16, 1999
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study GroupC Torp-Pedersen, M Møller, P E Bloch-Thomsen, et al.
Clinical Trials (London, England)|June 2, 2023
Now is the time to fix the clinical research workforce crisisStephanie A Freel, Denise C Snyder, Kara Bastarache, et al.
Lancet (London, England)|January 6, 2001
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trialL Køber, P E Bloch Thomsen, M Møller, et al.
The Science of the Total Environment|April 10, 2024
Temporal drivers of tryptophan-like fluorescent dissolved organic matter along a river continuumN A Harris, J P R Sorensen, B Marchant, et al.
The Science of the Total Environment|March 21, 2025
Corrigendum to "Temporal drivers of tryptophan-like fluorescent dissolved organic matter along a river continuum" [Sci. Total Environ. (2024) 172285]N A Harris, J P R Sorensen, B Marchant, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Model-based drug development: a rational approach to efficiently accelerate drug developmentP A Milligan, M J Brown, B Marchant, et al.
Pageof 7